RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$126.6B
P/E ratio
32x
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and cash equivalents1134842305366498095358131,4681,6182,1942,8863,1062,730
Marketable securities13743781582522365035971,3421,5971,3932,8094,6368,115
Accounts receivable, net14285937877391,1521,3431,5391,7242,1003,1126,0375,3295,667
Inventories---701292393997261,1511,4161,9171,9512,4022,581
Prepaid expenses and other current assets-23579671164131225243387161332411387
Total current assets3586531,2061,7972,1672,9153,1804,3356,4487,6899,77914,01515,88419,479
Marketable securities3702762713904606328641,4861,7553,2573,1366,8386,5925,397
Property, plant, and equipment, net---------2,8903,2223,4823,7634,146
Intangible assets, net------------9161,039
Deferred tax assets--------8298248598771,7242,575
Other noncurrent assets719235362078127145168223336444
Total assets1,0891,3242,0802,9513,8725,6096,9738,76411,73514,80517,16325,43529,21533,080
Accounts payable--------218418476564589607
Accrued Liabilities and Other Liabilities--------7721,0871,5222,2072,0742,358
Finance lease liabilities-----------720--
Deferred revenue--------453592-442478459
Deferred revenue--------453592-442478459
Total current liabilities1091481642996558111,2411,1351,4432,0972,6973,9333,1413,423
Total current liabilities1091481642996558111,2411,1351,4432,0972,6973,9333,1413,423
Long-term debt----------1,9791,9801,9811,983
Finance lease liabilities---------714717-720720
Deferred revenue--------464619-7370127
Other noncurrent liabilities7671141116100152362286-680638854
Total liabilities5628388359991,3301,9542,5242,6202,9773,7166,1386,6666,5517,107
Preferred Stock, Value, Issued0-------------
Class A Stock00000000------
Common Stock--000000000000
Common stock00------------
Additional paid-in capital1,5761,7551,7642,0462,4043,1003,0303,5133,9124,4296,7168,0889,94911,354
Retained earnings-1,046-1,267-517-932558531,7482,9475,2547,38010,89318,96823,30727,260
Accumulated other comprehensive loss-2-2-1-1529-131-122129-26-239-81
Treasury Stock, at cost; 25.5 shares in 2023 and 22.6 shares in 2022------------10,35312,560
Class A Stock0---0000------
Common Stock----0000000---
Total stockholders' equity5284861,2451,9522,5423,6554,4496,1448,75711,09011,02518,76922,66425,973
Total liabilities and stockholders' equity1,0891,3242,0802,9513,8725,6096,9738,76411,73514,80517,16325,43529,21533,080